Success Stories: EB1A Approval Granted to Cardiovascular Disease Researcher Despite RFE

Client’s Testimonial:

“Thank you for all your help and guidance.”

On May 1^st, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for an Interventional Cardiologist in the Field of Cardiovascular Disease (Approval Notice).

General Field: Cardiovascular Disease

Position at the Time of Case Filing: Interventional Cardiologist

Country of Origin: India

State of Residence at the Time of Filing: Arizona

Approval Notice Date: May 1^st, 2025

Processing Time: 3 months, 28 days (Premium Processing Requested)

Case Summary:
We are pleased to announce the approval of an I-140 petition under the EB1A (Alien of Extraordinary Ability) category for a distinguished cardiovascular researcher originally from India. Despite receiving a Request for Evidence (RFE), our strategic and evidence-rich response led to a favorable decision issued on May 1, 2025 — just under four months from the original filing date of January 3, 2025.

Our client is a leading figure in interventional cardiology, with extensive work on coronary artery disease, structural heart disease, and cardiovascular care during pandemics. His cutting-edge research has contributed to enhanced treatments for coronary complications, improved interventional techniques, and innovative therapeutic strategies addressing cardiac risks during public health emergencies.

Currently working in the United States as a practicing interventional cardiologist, he continues to drive forward the development of safer, minimally invasive cardiovascular interventions with a focus on improving long-term patient outcomes.

To support this petition, we presented a robust record of achievement:

● Publications: 81 peer-reviewed journal articles and 49 conference abstracts.

● Citations: His work has been cited over 1,110 times, placing him among the top 1% most-cited researchers in cardiovascular medicine.

● Review Service: Over 100 peer reviews for top journals such as JACC: Cardiovascular Interventions and Circulation: Cardiovascular Quality and Outcomes.

● Editorial Roles: Board member for respected cardiology journals.

● Recognition: Numerous invited talks and speaking engagements at major international cardiovascular conferences.

● Research Funding & Impact: His published work has informed major clinical trials, national treatment guidelines, and global cost-benefit models in cardiac care.

One of the supporting recommendation letters noted:

“Dr. [Client]’s work on drug-coated balloon therapies and structural interventions has shaped modern clinical approaches and trial designs, helping physicians worldwide improve outcomes for high-risk cardiovascular patients.”

To demonstrate his significance, we documented how:

● His findings have been implemented in clinical trials, multinational treatment protocols, and public health strategies.

● Multiple publications rank among the top 10% most-cited for their publication years in clinical medicine.

● His innovative techniques — including micropuncture access and advanced imaging for stent restenosis — are now considered standard references in interventional cardiology literature.

Our detailed petition addressed both prongs of the EB1A final merits determination, providing extensive independent citations, evidence of peer recognition, and proof of sustained international acclaim.

This approval, especially in the face of an RFE, underscores both the outstanding nature of our client’s contributions and the effectiveness of a well-structured petition. We are honored to have supported this accomplished physician-scientist and look forward to his continued success as a leader in cardiovascular medicine in the U.S.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.